Back
Day Range
$221.39
$227.98
52-Week Range
$216.49
$354.88
Volume
498,153
50D / 200D Avg
$253.15
/
$297.10
Prev Close
$227.08
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 64.2 | 0.3 |
| P/B | 10.5 | 2.9 |
| ROE % | 18.1 | 3.7 |
| Net Margin % | 9.1 | 3.8 |
| Rev Growth 5Y % | 25.3 | 10.0 |
| D/E | 0.7 | 0.2 |
Analyst Price Target
Hold
$357.25
+58.4%
Low: $286.00
High: $435.00
Forward P/E
35.8
Forward EPS
$6.34
EPS Growth (est.)
+0.0%
Est. Revenue
3.3 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$14.53
$13.75 – $14.90
|
6.1 B | 5 |
| FY2029 |
$12.78
$12.10 – $13.11
|
5.5 B | 2 |
| FY2028 |
$10.20
$9.98 – $10.70
|
4.7 B | 7 |
Key Takeaways
Revenue grew 25.30% annually over 5 years — strong growth
Earnings declined -40.93% over the past year
ROE of 18.12% — decent returns on equity
Generating 377.70M in free cash flow
P/E of 64.24 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.43%
Growth
Revenue Growth (5Y)
25.30%
Revenue (1Y)30.73%
Earnings (1Y)-40.93%
FCF Growth (3Y)132.12%
Quality
Return on Equity
18.12%
ROIC13.85%
Net Margin9.12%
Op. Margin17.50%
Safety
Debt / Equity
0.69
Current Ratio2.78
Interest Coverage5.94
Valuation
P/E Ratio
64.24
P/B Ratio10.48
EV/EBITDA34.21
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 30.73% | Revenue Growth (3Y) | 26.32% |
| Earnings Growth (1Y) | -40.93% | Earnings Growth (3Y) | 9.44% |
| Revenue Growth (5Y) | 25.30% | Earnings Growth (5Y) | 95.84% |
| Profitability | |||
| Revenue (TTM) | 2.71B | Net Income (TTM) | 247.10M |
| ROE | 18.12% | ROA | 7.75% |
| Gross Margin | 71.63% | Operating Margin | 17.50% |
| Net Margin | 9.12% | Free Cash Flow (TTM) | 377.70M |
| ROIC | 13.85% | FCF Growth (3Y) | 132.12% |
| Safety | |||
| Debt / Equity | 0.69 | Current Ratio | 2.78 |
| Interest Coverage | 5.94 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 64.24 | P/B Ratio | 10.48 |
| P/S Ratio | 5.86 | PEG Ratio | -1.96 |
| EV/EBITDA | 34.21 | Dividend Yield | 0.00% |
| Market Cap | 15.87B | Enterprise Value | 16.21B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.71B | 2.07B | 1.70B | 1.31B | 1.10B |
| Net Income | 247.10M | 418.30M | 206.30M | 4.60M | 16.80M |
| EPS (Diluted) | 3.48 | 5.78 | 2.94 | 0.07 | 0.25 |
| Gross Profit | 1.94B | 1.45B | 1.16B | 805.60M | 752.10M |
| Operating Income | 473.80M | 308.90M | 220.00M | 37.60M | 126.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.19B | 3.09B | 2.59B | 2.25B | 2.05B |
| Total Liabilities | 1.68B | 1.88B | 1.86B | 1.77B | 1.49B |
| Shareholders' Equity | 1.52B | 1.21B | 732.70M | 476.40M | 556.30M |
| Total Debt | 1.05B | 1.42B | 1.45B | 1.43B | 1.29B |
| Cash & Equivalents | 716.10M | 953.40M | 650.70M | 623.90M | 791.60M |
| Current Assets | 1.89B | 1.87B | 1.57B | 1.30B | 1.32B |
| Current Liabilities | 680.10M | 528.40M | 451.20M | 364.70M | 228.80M |